US equities
|
NVDA
$238.67
▲+2.02%
SPCX
$167.15
▲+5.15%
MU
$1,063.95
▼-1.02%
TSLA
$380.34
▲+2.63%
MSFT
$525.68
▲+1.58%
SNDK
$1,709.45
▼-0.61%
INTC
$117.26
▼-1.73%
META
$743.07
▲+2.06%
NVDA
$238.67
▲+2.02%
SPCX
$167.15
▲+5.15%
MU
$1,063.95
▼-1.02%
TSLA
$380.34
▲+2.63%
MSFT
$525.68
▲+1.58%
SNDK
$1,709.45
▼-0.61%
INTC
$117.26
▼-1.73%
META
$743.07
▲+2.06%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Ventyx Biosciences, Inc. - Common Stock
(NQ:
VTYX
)
14.00
UNCHANGED
Last Price
Updated: 4:00 PM EST, Mar 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ventyx Biosciences, Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTYX
March 19, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 19, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ventyx Biosciences, Inc. (NASDAQ: VTYX): (i) pursuant...
Via
TheNewswire.com
Topics
Lawsuit
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTYX
March 19, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Children’s Place, and Ventyx and Encourages Investors to Contact the Firm
March 19, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTYX
March 18, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTYX
March 18, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 18, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ventyx Biosciences, Inc. (NASDAQ: VTYX): (i) pursuant...
Via
TheNewswire.com
Topics
Lawsuit
Robbins LLP Urges VTYX Investors with Large Losses to Contact the Firm Before April 30, 2024, for Information About Their Rights
March 18, 2024
From
Robbins LLP
Via
Business Wire
VENTYX BIOSCIENCES, INC. (NASDAQ: VTYX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ventyx Biosciences, Inc.
March 18, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTYX
March 17, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTYX
March 17, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 17, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ventyx Biosciences, Inc. (NASDAQ: VTYX): (i) pursuant...
Via
TheNewswire.com
Topics
Lawsuit
ROSEN, A LEADING LAW FIRM, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTYX
March 17, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTYX
March 16, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTYX
March 16, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 16, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ventyx Biosciences, Inc. (NASDAQ: VTYX): (i) pursuant...
Via
TheNewswire.com
Topics
Lawsuit
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTYX
March 15, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTYX
March 15, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 15, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ventyx Biosciences, Inc. (NASDAQ: VTYX): (i) pursuant...
Via
TheNewswire.com
Topics
Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Children’s Place, and Ventyx and Encourages Investors to Contact the Firm
March 15, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ventyx Biosciences, Inc. (VTYX)
March 14, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
DEADLINE ALERT: Bernstein Liebhard LLP Reminds Ventyx Biosciences, Inc. Investors of Upcoming Deadline
March 14, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTYX
March 12, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTYX
March 12, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 12, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ventyx Biosciences, Inc. (NASDAQ: VTYX): (i) pursuant...
Via
TheNewswire.com
Topics
Lawsuit
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ventyx Biosciences, Inc. (VTYX)
March 12, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
VTYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ventyx Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
March 12, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Children’s Place, and Ventyx and Encourages Investors to Contact the Firm
March 11, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTYX
March 11, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTYX
March 11, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 11, 2024 - Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Ventyx...
Via
TheNewswire.com
Topics
Lawsuit
VENTYX BIOSCIENCES, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Ventyx Biosciences, Inc. (NASDAQ: VTYX)
March 11, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Dow Turns Higher; GDS Holdings Shares Climb
↗
March 11, 2024
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning higher on Monday. The Dow traded up 0.08% to 38,753.49 while the NASDAQ fell 0.20% to 16,052.34. The S&P 500 also...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Monday's Intraday Session
↗
March 11, 2024
Via
Benzinga
Crude Oil Edges Higher; Lexicon Pharmaceuticals Shares Jump
↗
March 11, 2024
U.S. stocks traded lower midway through trading, with the Dow Jones index dipping over 50 points on Monday. The Dow traded down 0.16% to 38,662.09 while the NASDAQ fell 0.26% to 16,043.75. The S&P 500...
Via
Benzinga
Topics
Stocks
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
March 11, 2024
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart...
Via
Benzinga
What's Going On With Autoimmune/Inflammatory Disorder-Focused Ventyx Biosciences On Monday?
↗
March 11, 2024
Ventyx Biosciences provides clinical and pipeline updates, revealing compelling results in NLRP3 inhibitor development. CEO Raju Mohan announces pipeline reprioritization and strategic financing for...
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
